Medical Home»Lilly claims another head-to-head victory over Lantus in PhIII diabetes showdown - FierceBiotech

Lilly claims another head-to-head victory over Lantus in PhIII diabetes showdown - FierceBiotech

Share  Email
Date : 4th-Sep-2014 06:02:03 AM
Title : Lilly claims another head-to-head victory over Lantus in PhIII diabetes showdown - FierceBiotech

Lilly claims another head-to-head victory over Lantus in PhIII diabetes showdown
FierceBiotech
Beating Lantus has been a big focus in diabetes drug development, a game of one upmanship as the world's dominant players in the field jockey for a better position in the fast-growing megablockbuster drug market. Eli Lilly, though, which has had to cut ...
Lilly's diabetes drug trumps Sanofi's in late-stage trialsReuters
Lilly says insulin fares well in late-stage testsBellingham Herald


more...<< Back

Other Recent NewsFeed

As of 04:01:00 PM PST
FOLFOXIRI and bevacizumab in metastatic colorectal cancer First-line bevacizumab with fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) improves survival outcomes in patients with metastatic colorectal cancer, according to a new trial.... More | Save |  Share  Email
Late detection of lung cancer 30% of patients with lung cancer die within 90 days of diagnosis, according to a new study. Moreover, these patients usually had more interactions with primary care before their diagnosis (median of f... More | Save |  Share  Email
Australian HPV vaccination programme yields results A newstudy suggests the prevalence of oncogenic strains of human papillomavirus (HPV) in young Australian women has fallen to the lowest level in high-income countries after a national human papillo... More | Save |  Share  Email
US hospitals object to changes in Genentech drug distribution Genentech's change in distribution of bevacizumab, trastuzumab, and rituximab to a specialty distribution system, represents a de-facto price hike that could cost US hospitals millions of dollars, as ... More | Save |  Share  Email
View All...
The 2014 RegMed Capital Conference @ The World Stem Cell Summit
 
Subscribe
x